Journal article
Initial report of RTOG 9601, a phase III trial in prostate cancer: Effect of anti-androgen therapy (AAT) with bicalutamide during and after radiation therapy (RT) on freedom from progression and incidence of metastatic disease in patients following radical prostatectomy (RP) with pT2-3,N0 disease and elevated PSA levels.
Abstract
1
Background: To test if long term AAT when combined with RT in these patients (pts) with prostate cancer (PC) will improve cancer control outcomes as well as overall survival (OS).
Authors
Shipley WU; Hunt D; Lukka HR; Major P; Heney NM; Grignon D; Patel M; Bahary J; Lawton CA; Sandler HM
Journal
Journal of Clinical Oncology, Vol. 29, No. 7_suppl, pp. 1–1
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
March 1, 2011
DOI
10.1200/jco.2011.29.7_suppl.1
ISSN
0732-183X